Segment Reporting - Additional Information (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2021 USD ($) segment	Dec. 31, 2020 USD ($)	Dec. 31, 2019
Segment Reporting Information [Line Items]
Number of operating business segment | segment	1
Property, plant and equipment, net	$ 60,510	$ 59,662
United States
Segment Reporting Information [Line Items]
Property, plant and equipment, net	56,100	54,500
India
Segment Reporting Information [Line Items]
Property, plant and equipment, net	$ 4,400	$ 5,100
Revenue | UCB | Customer Concentration Risk
Segment Reporting Information [Line Items]
Percentage revenue from customers	36.00%	23.00%	28.00%
Revenue | Baxalta Incorporated Or Takeda P L C | Customer Concentration Risk
Segment Reporting Information [Line Items]
Percentage revenue from customers	23.00%	14.00%	19.00%
Revenue | Astra Zeneca Ab | Customer Concentration Risk
Segment Reporting Information [Line Items]
Percentage revenue from customers	16.00%	13.00%	17.00%
Revenue | Pfizer | Customer Concentration Risk
Segment Reporting Information [Line Items]
Percentage revenue from customers	13.00%
Revenue | BMS | Customer Concentration Risk
Segment Reporting Information [Line Items]
Percentage revenue from customers		33.00%
Property, Plant and Equipment | Geographic Concentration Risk | United States
Segment Reporting Information [Line Items]
Percentage revenue from customers	93.00%	91.00%
Property, Plant and Equipment | Geographic Concentration Risk | India
Segment Reporting Information [Line Items]
Percentage revenue from customers	7.00%	9.00%